CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2012
Filed with the SEC on Aug 7, 2012 and accepted by EDGAR at Aug 7, 2012, 16:44 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-04-01 to 2012-06-30 | $30.71bn | us-gaap:Revenues |
| Revenue | 6 months2012-01-01 to 2012-06-30 | $61.51bn | us-gaap:Revenues |
| Cost of revenue | 3 months2012-04-01 to 2012-06-30 | $25.27bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2012-01-01 to 2012-06-30 | $50.95bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2012-04-01 to 2012-06-30 | $5.45bn | us-gaap:GrossProfit |
| Gross profit | 6 months2012-01-01 to 2012-06-30 | $10.56bn | us-gaap:GrossProfit |
| Operating income | 3 months2012-04-01 to 2012-06-30 | $1.71bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-01-01 to 2012-06-30 | $3.11bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-04-01 to 2012-06-30 | $132.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2012-01-01 to 2012-06-30 | $264.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-04-01 to 2012-06-30 | $610.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-01-01 to 2012-06-30 | $1.11bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-04-01 to 2012-06-30 | $965.0m | us-gaap:ProfitLoss |
| Net income | 6 months2012-01-01 to 2012-06-30 | $1.74bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2012-04-01 to 2012-06-30 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-01-01 to 2012-06-30 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-04-01 to 2012-06-30 | $0.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-01-01 to 2012-06-30 | $1.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-04-01 to 2012-06-30 | 1,287,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-01-01 to 2012-06-30 | 1,298,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-01-01 to 2012-06-30 | $4.02bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2012-01-01 to 2012-06-30 | $818.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2012-01-01 to 2012-06-30 | $420.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2012-01-01 to 2012-06-30 | $2.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-06-30 | $1.82bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-06-30 | $19.30bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-06-30 | $65.59bn | us-gaap:Assets |
| Current liabilities | At period end2012-06-30 | $13.14bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2012-06-30 | $9.21bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-06-30 | $5.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2012-06-30 | $200.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2012-06-30 | $37.91bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001104659-12-055261. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.